Source: ALL
| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
ATPase H+/K+ transporting non-gastric alpha2 subunit | 0.575 | 0.769 | 7.1E-14 |
|
disease | 0.100 | None | 0.909 | 22 | 0 | 2003 | 2019 | ||||||||
|
ATPase H+/K+ transporting subunit alpha | 0.575 | 0.769 | 9.4E-12 |
|
disease | 0.100 | None | 0.909 | 22 | 0 | 2003 | 2019 | ||||||||
|
cytochrome P450 family 2 subfamily C member 19 | 0.467 | 0.846 | 6.5E-20 |
|
disease | 0.100 | None | 1.000 | 18 | 0 | 2002 | 2019 | ||||||||
|
Gastroesophageal reflux | 0.678 | 0.538 |
|
disease | 0.100 | None | 0.923 | 13 | 0 | 2005 | 2020 | |||||||||
|
C-X-C motif chemokine ligand 8 | 0.310 | 0.962 | 2.7E-04 |
|
disease | 0.360 | None | 1.000 | 8 | 0 | 2003 | 2018 | ||||||||
|
Pulmonary disease, chronic obstructive, severe early-onset | 0.456 | 0.885 |
|
disease | 0.070 | None | 1.000 | 7 | 0 | 2014 | 2019 | |||||||||
|
tumor protein p63 | 0.362 | 0.769 | 1.00 |
|
disease | 0.200 | None | 1.000 | 6 | 0 | 1999 | 2011 | ||||||||
|
immunoglobulin superfamily containing leucine rich repeat 2 | 0.821 | 0.115 | 0.11 |
|
disease | 0.060 | None | 0.833 | 6 | 0 | 2017 | 2019 | ||||||||
|
F2R like trypsin receptor 1 | 0.480 | 0.769 | 1.5E-04 |
|
disease | 0.060 | None | 1.000 | 6 | 0 | 2009 | 2018 | ||||||||
|
prostaglandin-endoperoxide synthase 2 | 0.314 | 0.962 | 1.00 |
|
disease | 0.350 | None | 1.000 | 6 | 0 | 2004 | 2018 | ||||||||
|
caudal type homeobox 2 | 0.458 | 0.769 | 0.53 |
|
disease | 0.050 | None | 1.000 | 5 | 0 | 2009 | 2019 | ||||||||
|
interleukin 1 beta | 0.276 | 0.962 | 0.13 |
|
disease | 0.050 | None | 1.000 | 5 | 0 | 2004 | 2014 | ||||||||
|
fucosyltransferase 3 (Lewis blood group) | 0.606 | 0.615 | 6.3E-05 |
|
disease | 0.050 | None | 1.000 | 5 | 0 | 2018 | 2020 | ||||||||
|
carbonic anhydrase 1 | 0.623 | 0.769 | 4.7E-11 |
|
disease | 0.040 | None | 0.750 | 4 | 0 | 2017 | 2019 | ||||||||
|
MT-CO2 pseudogene 12 | 0.368 | 0.962 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 2004 | 2018 | |||||||||
|
eukaryotic translation initiation factor 6 | 0.584 | 0.538 | 0.24 |
|
disease | 0.040 | None | 0.750 | 4 | 0 | 2017 | 2019 | ||||||||
|
protein tyrosine phosphatase non-receptor type 11 | 0.385 | 0.923 | 1.00 |
|
disease | 0.100 | None | 1.000 | 4 | 1 | 2003 | 2006 | ||||||||
|
neural proliferation, differentiation and control 1 | 0.711 | 0.423 | 3.0E-02 |
|
disease | 0.040 | None | 0.750 | 4 | 0 | 2017 | 2019 | ||||||||
|
cytochrome c oxidase subunit II | 0.352 | 0.962 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 2004 | 2018 | |||||||||
|
transient receptor potential cation channel subfamily V member 1 | 0.446 | 0.885 | 1.0E-16 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2010 | 2016 | ||||||||
|
interleukin 1 receptor antagonist | 0.373 | 0.923 | 3.1E-02 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2004 | 2013 | ||||||||
|
gastrin | 0.485 | 0.808 | 2.7E-03 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2017 | 2019 | ||||||||
|
SRY-box transcription factor 2 | 0.405 | 0.808 | 0.71 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2016 | 2016 | ||||||||
|
solute carrier family 52 member 1 | 0.526 | 0.769 | 3.5E-06 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2010 | 2016 | ||||||||
|
selenocysteine lyase | 0.530 | 0.731 | 2.3E-09 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2018 | 2019 |